Journal of Bone and Joint Infection
Journal of Bone and Joint Infection
JBJI
Articles | Volume 10, issue 2
Articles | Volume 10, issue 2
https://doi.org/10.5194/jbji-10-93-2025
© Author(s) 2025. This work is distributed under
the Creative Commons Attribution 4.0 License.
https://doi.org/10.5194/jbji-10-93-2025
© Author(s) 2025. This work is distributed under
the Creative Commons Attribution 4.0 License.
Articles | Volume 10, issue 2
Original full-length article
 | 
31 Mar 2025
Original full-length article |  | 31 Mar 2025

Dalbavancin to facilitate early discharge in the treatment of complex musculoskeletal infections: a multi-centre real-life application

Tariq Azamgarhi, Simon Warren, Antonia Scobie, Natasha Karunaharan, Cristina Perez-Sanchez, Rebecca Houghton, Salma Hassan, Julie Lourtet-Hascoët, Hannah Kershaw, Parham Sendi, and Kordo Saeed

Viewed

Total article views: 25 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
25 0 0 25 0 0
  • HTML: 25
  • PDF: 0
  • XML: 0
  • Total: 25
  • BibTeX: 0
  • EndNote: 0
Views and downloads (calculated since 31 Mar 2025)
Cumulative views and downloads (calculated since 31 Mar 2025)

Viewed (geographical distribution)

Total article views: 25 (including HTML, PDF, and XML) Thereof 25 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 01 Apr 2025
Download
Short summary
This study evaluates dalbavancin, an antibiotic with a long duration of action, in treating complex bone and joint infections. It does not require daily dosing, allowing patients to leave the hospital earlier and reducing costs. Dalbavancin is shown to be effective and safe, especially for patients unsuitable for oral antibiotics or outpatient therapy, achieving similar results to traditional treatments while cutting healthcare costs.
Read more
Share